Searchable abstracts of presentations at key conferences on calcified tissues

Bone Abstracts

Published by BioScientifica
Previous issue | Volume 5 | ECTS2016 | Next issue

43rd Annual European Calcified Tissue Society Congress

Rome, Italy
14 May 2016 - 17 May 2016

Card image cap

Cancer and Bone Oral Communications

Oral Communications

Table of contents
Next section
Oral Poster Talks

ba0005cabs.oc1.1 | Oral Communications

Secreted YB-1 (Y-box binding protein 1) as a biomarker of bone disease progression in patients with breast cancer and bone metastases

ba0005cabs.oc1.2 | Oral Communications

Bone and metabolic parameters are associated with overall survival in patients with bone metastases from adenocarcinoma lung cancer: the POUMOS study

ba0005cabs.oc1.3 | Oral Communications

Blocking IL-1R signalling inhibits breast cancer growth and bone metastases by altering the tumour microenvironment

ba0005cabs.oc2.1 | Oral Communications

Prostate cancer microRNAs in extracellular vesicles stimulate osteoclastogenesis

ba0005cabs.oc2.2 | Oral Communications

Integrin α5 is an independent prognosis factor and a potential therapeutic target for breast cancer bone metastasis

ba0005cabs.oc2.3 | Oral Communications

Cancer cell homing to the bone marrow is modulated by the mesenchymal stromal cell

ba0005cabs.oc2.4 | Oral Communications

Peripheral tumour re-growth following combination therapy – role of the bone microenvironment

ba0005cabs.oc2.5 | Oral Communications

Inhibition of BMP signalling reduces bone destruction and impacts niche maintenance in a mouse model of multiple myeloma

ba0005cabs.oc3.1 | Oral Communications

Blockade of C5aR impairs tumor-induced osteoclastogenesis preventing bone metastasis colonization in lung cancer

ba0005cabs.oc3.2 | Oral Communications

Osteoblasts inhibit the immune response against cancer

ba0005cabs.oc3.3 | Oral Communications

Visualizing the tumor immunity in living bone marrow by intravital 2-photon imaging

ba0005cabs.oc3.4 | Oral Communications

Anti-sclerostin treatment prevents multiple myeloma bone disease and reduces tumour burden

ba0005cabs.oc3.5 | Oral Communications

Targeting skeletal metastatic breast cancer with bisphosphonic matrix metalloproteinase-2 inhibitors

ba0005cabs.oc4.1 | Oral Communications

Muscle dysfunction in immune competent mice with osteolytic breast cancer in bone is associated with skeletal muscle oxidation of RyR1

ba0005cabs.oc4.2 | Oral Communications

Bisphosphonates prevent osteolysis and muscle weakness in aromatase inhibitor-treated mice with breast cancer bone metastases

ba0005cabs.oc4.3 | Oral Communications

In vitro mechanotransduction of osteosarcoma cells

ba0005cabs.oc4.4 | Oral Communications

3D tissue engineered constructs for modeling tumor-induced bone disease

ba0005cabs.oc4.5 | Oral Communications

New models of breast and lung cancer bone metastases for preclinical efficacy testing

Published by BioScientifica

Bone Abstracts
ISSN 2052-1219 (online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more